Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;2(4):a001040.
doi: 10.1101/cshperspect.a001040. Epub 2009 Dec 2.

p53 regulation of metabolic pathways

Affiliations
Review

p53 regulation of metabolic pathways

Eyal Gottlieb et al. Cold Spring Harb Perspect Biol. 2010 Apr.

Abstract

During the course of tumorigenesis, cells acquire a number of alterations that contribute to the acquisition of the malignant phenotype, allowing them to survive and flourish in increasingly hostile environments. Cancer cells can be characterized by perturbations in the control of cell proliferation and growth, resistance to death, and alterations in their interactions with the microenvironment. Underpinning many of these changes are shifts in metabolism that allow cancer cells to use alternative pathways for energy production and building the macromolecules necessary for growth, as well as regulating the generation of signaling molecules such as reactive oxygen species (ROS). In the past few years, it became clear that p53, the most studied, if not most important, tumor suppressor protein, can also directly control metabolic traits of cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The main energy-generating metabolic pathways, and their regulation by p53. By promoting oxidative phosphorylation and inhibiting glycolysis, p53 might oppose the Warburg effect that is seen in many cancers. Promotion of the pentose phosphate pathway would also provide survival functions and may contribute to anabolic pathways necessary for damage repair.
Figure 2.
Figure 2.
p53 drives different responses under conditions of low stress (where cell survival and repair is supported) and high stress (where the damaged cell is eliminated though death or senescence). However, the inappropriate maintenance of the low-stress functions may contribute to cancer cell survival and growth.

References

    1. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM 1998. Stabilization of wild-type p53 by hypoxia-inducible factor 1a. Nature 392:405–408 - PubMed
    1. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–120 - PubMed
    1. Bertheau P, Espie M, Turpin E, Lehmann J, Plassa L-F, Varna M, Janin A, de The H 2008. TP53 status and response to chemotherapy in breast cancer. Pathobiology 75:132–139 - PubMed
    1. Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B, Brown EJ, Nathanson KL, Simon MC 2009. HIF2{α} inhibition promotes p53 pathway activity, tumor cell death, radiation responses. Proc Natl Acad Sci 106:14391–14396 - PMC - PubMed
    1. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L 1998. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273:11995–11998 - PubMed

Publication types

Substances